These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


380 related items for PubMed ID: 17461696

  • 1. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA.
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [Abstract] [Full Text] [Related]

  • 2. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA, Ng TM, Van Tassell BW.
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [Abstract] [Full Text] [Related]

  • 3. Nesiritide: harmful or harmless?
    Dorsch MP, Rodgers JE.
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [Abstract] [Full Text] [Related]

  • 4. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [Abstract] [Full Text] [Related]

  • 5. Nesiritide: trials and tribulations.
    Arora RR.
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA, Hernandez AF.
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [Abstract] [Full Text] [Related]

  • 7. [Nesiritide in heart failure: commercial success or therapeutic advance?].
    Stampfli T, Perrier A.
    Rev Med Suisse; 2006 Jan 25; 2(50):295-8. PubMed ID: 16503047
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of nesiritide for the treatment of decompensated heart failure.
    Emerman CL.
    Rev Cardiovasc Med; 2002 Jan 25; 3 Suppl 4():S28-34. PubMed ID: 12439428
    [Abstract] [Full Text] [Related]

  • 9. Short and long-term mortality with nesiritide.
    Arora RR, Venkatesh PK, Molnar J.
    Am Heart J; 2006 Dec 25; 152(6):1084-90. PubMed ID: 17161057
    [Abstract] [Full Text] [Related]

  • 10. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
    Dandamudi S, Chen HH.
    Expert Rev Cardiovasc Ther; 2012 May 25; 10(5):557-63. PubMed ID: 22651831
    [Abstract] [Full Text] [Related]

  • 11. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF, O'Connor CM, Starling RC, Reist CJ, Armstrong PW, Dickstein K, Lorenz TJ, Gibler WB, Hasselblad V, Komajda M, Massie B, McMurray JJ, Nieminen M, Rouleau JL, Swedberg K, Califf RM.
    Am Heart J; 2009 Feb 25; 157(2):271-7. PubMed ID: 19185633
    [Abstract] [Full Text] [Related]

  • 12. Intravenous nesiritide in acute heart failure.
    Knox MA, Dancy T, Mook W, Pschirer JJ.
    Am J Ther; 2005 Feb 25; 12(3):233-7. PubMed ID: 15891267
    [Abstract] [Full Text] [Related]

  • 13. Effect of nesiritide in patients with acute decompensated heart failure.
    O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM.
    N Engl J Med; 2011 Jul 07; 365(1):32-43. PubMed ID: 21732835
    [Abstract] [Full Text] [Related]

  • 14. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J, ADHERE Scientific Advisory Committee and Investigators, ADHERE Study Group.
    J Am Coll Cardiol; 2005 Jul 05; 46(1):57-64. PubMed ID: 15992636
    [Abstract] [Full Text] [Related]

  • 15. Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
    Emerman CL.
    Rev Cardiovasc Med; 2003 Jul 05; 4 Suppl 7():S13-20. PubMed ID: 14668696
    [Abstract] [Full Text] [Related]

  • 16. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ, Dowling TC, Meadows D, Ayala T, Marshall J, Minshall S, Greenberg N, Thattassery E, Fisher ML, Rao K, Gottlieb SS.
    Circulation; 2004 Sep 21; 110(12):1620-5. PubMed ID: 15337695
    [Abstract] [Full Text] [Related]

  • 17. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.
    Yancy CW.
    Drug Saf; 2007 Sep 21; 30(9):765-81. PubMed ID: 17722969
    [Abstract] [Full Text] [Related]

  • 18. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D, Burger AJ.
    Am Heart J; 2004 Nov 21; 148(5):e16. PubMed ID: 15523294
    [Abstract] [Full Text] [Related]

  • 19. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
    Ezekowitz JA, Hernandez AF, Starling RC, Yancy CW, Massie B, Hill JA, Krum H, Diaz R, Ponikowski P, Metra M, Howlett JG, Gennevois D, O'Connor CM, Califf RM, Fonarow GC.
    Am Heart J; 2009 Feb 21; 157(2):219-28. PubMed ID: 19185628
    [Abstract] [Full Text] [Related]

  • 20. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
    Sackner-Bernstein JD, Skopicki HA, Aaronson KD.
    Circulation; 2005 Mar 29; 111(12):1487-91. PubMed ID: 15781736
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.